Lukas Van De Sand

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction.

Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction.

Journal: Chronic respiratory disease

Published: April 22, 2026

Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination.

Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination.

Journal: mSphere

Published: February 26, 2026

Landouzy sepsis in a young adult with multiorgan failure: successful ECMO-assisted management using an individualized antituberculous regimen.

Landouzy sepsis in a young adult with multiorgan failure: successful ECMO-assisted management using an individualized antituberculous regimen.

Journal: BMC infectious diseases

Published: December 28, 2025

Hemoptysis in a patient with MDR-tuberculosis: successful diagnosis with photon counting CT and embolization of a Rasmussen aneurysm.

Hemoptysis in a patient with MDR-tuberculosis: successful diagnosis with photon counting CT and embolization of a Rasmussen aneurysm.

Journal: Infection

Published: August 21, 2025

Evaluation of T-Cell Responses Following Sequential Vaccination with PCV13 and PPSV23 Against Streptococcus pneumoniae in Patients with Psoriasis.

Evaluation of T-Cell Responses Following Sequential Vaccination with PCV13 and PPSV23 Against Streptococcus pneumoniae in Patients with Psoriasis.

Journal: Vaccines

Published: July 25, 2025

Sequential Vaccination Against Streptococcus pneumoniae Appears as Immunologically Safe in Clinically Stable Kidney Transplant Recipients.

Sequential Vaccination Against Streptococcus pneumoniae Appears as Immunologically Safe in Clinically Stable Kidney Transplant Recipients.

Journal: Vaccines

Published: August 09, 2024

Antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy.

Antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy.

Journal: mBio

Published: June 04, 2024

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Journal: The Journal of clinical investigation

Published: January 18, 2024

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients.

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients.

Journal: Infection

Published: February 22, 2023

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.

Journal: Frontiers in immunology

Published: January 24, 2023

Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.

Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.

Journal: Frontiers in immunology

Published: January 13, 2023

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.

Journal: Journal of clinical medicine

Published: November 26, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026